Dr Tim Shannon joins Canaan Partners
This article was originally published in Scrip
Executive Summary
The venture capital firm Canaan Partners (US) has named Dr Tim Shannon venture partner. Dr Shannon has more than 15 years' biopharmaceutical industry experience, having most recently served as president and chief executive officer of CuraGen, a biopharmaceutical company focused on oncology, which was acquired by Celldex Therapeutics in October.